ON DEMAND WEBINAR:

SEP-1 is Changing...are You Prepared for What's Ahead in 2026?

SEP-1 has moved beyond a quality reporting exercise. As performance tied to Value-Based Purchasing begins to materially impact hospital reimbursement, sepsis-related decisions increasingly carry meaningful financial, operational, and clinical consequences.

Many health systems continue to manage sepsis through a compliance-first lens, aiming to avoid penalties while balancing complex and sometimes competing operational priorities. These approaches can unintentionally increase length of stay, strain emergency department flow, limit inpatient capacity and frustrate clinicians, while introducing reimbursement risk that is not always visible in real time.

 This webinar examines how those challenges are showing up across hospitals today and why long-standing sepsis strategies are being re-evaluated as payment realities evolve. Clinical leaders will unpack where organizations often misjudge their exposure, and how early decision - making at triage including emerging approaches that assess the patients' host response may influence outcomes well beyond SEP-1 checkboxes. 

The discussion will also explore how lessons learned from SEP-1 performance are shaping how organizations prepare for what comes next in federal sepsis measurement.

Key Learning Objectives:

  • Where compliance-first sepsis strategies create unintended system train
  • How early clinical decisions affect throughput and inpatient capacity
  • The relationship between SEP-1 performance, outcomes and reimbursement risk
  • What leaders should consider as Value-Based Purchasing stakes continue to rise
  • How emerging approaches to early sepsis assessment, including host-response insights, is influencing sepsis strategy
Thomas-1
Christopher Thomas, MD
Vice President, Chief Quality Officer, FMOL Health
Kraus, Chadd
Chadd K. Kraus, DO, DrPH, FACEP
Vice Chair, Research - Department of Emergency and Hospital Medicine, Jefferson Health - Lehigh Valley